Numerion Labs

Overview

Builds an AI platform that searches chemical space for novel drug-like molecules, supporting small-molecule drug discovery programs for immune and inflammatory diseases.

Part of the San Francisco ecosystem

Related

• 8VCBuilds and invests in technology companies, partnering with entrepreneurs to develop platforms addressing areas such as healthcare, zero-emission aircraft, privacy enforcement, and urban tunneling.
• Chai DiscoveryBuilds computer-aided molecular design software that models biochemical structure and interaction, helping scientists design new medicines and molecules on computers.
• General CatalystInvests in portfolio companies and acquired a hospital system to test a model for more proactive, accessible, affordable healthcare for American patients.
• Long Journey VenturesInvests early in companies and works with portfolio founders over the long term, supporting entrepreneurs building unconventional ideas and businesses.
• Lux CapitalInvests in emerging science and technology companies and publishes scenarios, analyses, podcasts, and newsletters for audiences tracking strategic challenges and future developments.
• MedraBuilds autonomous AI robotic lab systems that collect life science data and design, execute, interpret, and improve experiments in closed loops.
• Merge LabsCollect visitor inquiries and email list sign-ups through a launch landing page, enabling updates, promotions, and direct contact before the site opens.
• Periodic LabsBuilds AI scientists and autonomous laboratories for physical science experiments, including support for semiconductor manufacturers addressing chip heat dissipation issues.
• Refactor CapitalEarly-stage fund for foundational technology and biology. Founded by David Lee.
• Roots of ProgressBuilds a philosophy and culture of progress, supporting progress-focused intellectuals and communities through training, networking, events, collaboration, and idea exchange.
• Starlight VenturesStarlight Ventures backs founders using science and technology to transform large physical markets. Its portfolio and thesis span space, climate, energy, biotech, advanced materials, and AI-enabled infrastructure, making it a strong addition to the frontier investor set despite not being a single-sector fund.
• Verge GenomicsBuilds AI models and discovery tools using multimodal human CNS data to identify drug targets, match patients, and support neurological disease drug development.